A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group phase III randomized trial

S. J. Lauer, J. J. Shuster, D. H. Mahoney, N. Winick, S. Toledano, L. Munoz, G. Kiefer, J. D. Pullen, C. P. Steuber, B. M. Camitta

Research output: Contribution to journalArticlepeer-review

21 Scopus citations

Fingerprint

Dive into the research topics of 'A comparison of early intensive methotrexate/mercaptopurine with early intensive alternating combination chemotherapy for high-risk B-precursor acute lymphoblastic leukemia: A Pediatric Oncology Group phase III randomized trial'. Together they form a unique fingerprint.

Medicine & Life Sciences